PETER GANPAT: Open Payments
NPI 1255650081 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,208 in 65 payments from 17 companies in 2025. Trend: 2023 $684 · 2024 $650 · 2025 $1,208
Food & beverage: $1,201Education: $8
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $241 |
| Otsuka America Pharmaceutical, Inc. | 8 | $184 |
| ABBVIE INC. | 12 | $145 |
| Axsome Therapeutics, Inc. | 4 | $111 |
| E.R. Squibb & Sons, L.L.C. | 4 | $102 |
| Janssen Pharmaceuticals, Inc | 4 | $89 |
| Exact Sciences Corporation | 3 | $84 |
| Corium, LLC | 2 | $44 |
| Bausch Health US, LLC | 2 | $34 |
| Atland Pharmaceuticals, LLC | 1 | $29 |
Products named: CAPLYTA, REXULTI, Auvelity, VRAYLAR, Cologuard Collection Kit, COBENFY, SPRAVATO, Azstarys.
Industry payments across FL — which companies pay providers there.
